↓ Skip to main content

Dove Medical Press

Article Metrics

Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK

Overview of attention for article published in Cancer Management and Research, August 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

policy
1 policy source
googleplus
1 Google+ user

Readers on

mendeley
25 Mendeley
Title
Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK
Published in
Cancer Management and Research, August 2013
DOI 10.2147/cmar.s44539
Pubmed ID
Authors

Samantha Humphreys, Pellissier, Alison Jones

Abstract

Prevention of chemotherapy-induced nausea and vomiting (CINV) remains an important goal for patients receiving chemotherapy. The objective of this study was to define, from the UK payer perspective, the cost-effectiveness of an antiemetic regimen using aprepitant, a selective neurokinin-1 receptor antagonist, for patients receiving chemotherapy for breast cancer.

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 4%
Unknown 24 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 24%
Other 6 24%
Researcher 5 20%
Student > Ph. D. Student 3 12%
Student > Doctoral Student 2 8%
Other 2 8%
Unknown 1 4%
Readers by discipline Count As %
Medicine and Dentistry 10 40%
Agricultural and Biological Sciences 4 16%
Pharmacology, Toxicology and Pharmaceutical Science 3 12%
Chemistry 2 8%
Economics, Econometrics and Finance 1 4%
Other 2 8%
Unknown 3 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2019.
All research outputs
#3,890,777
of 14,551,860 outputs
Outputs from Cancer Management and Research
#89
of 937 outputs
Outputs of similar age
#47,325
of 183,131 outputs
Outputs of similar age from Cancer Management and Research
#2
of 4 outputs
Altmetric has tracked 14,551,860 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 937 research outputs from this source. They receive a mean Attention Score of 2.2. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,131 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.